Transvaginal aspiration of oocytes from hormone-treated pregnant beef cattle for in vitro fertilization.
The ability to produce oocytes from genetically valuable, pregnant donors in a safe, repeatable manner would broaden the application of in vitro fertilization (IVF) procedures for beef and dairy cattle. The objectives of this study were to evaluate two gonadotropin treatment schedules for follicle stimulation of pregnant donor cattle and to determine the efficacy and safety of the repeated oocyte aspiration procedure from pregnant cattle. In Exp. 1, pregnant donors at 60 to 90 d of gestation were randomly allotted to three treatment groups. Cows in Treatment A received a total dose of 40 mg of FSH. Cows in Treatment B were administered a total of 20 mg of FSH, and females in Treatment C served as pregnant vehicle-treated controls. A group of luteal phase cows received a total of 40 mg of FSH and served as nonpregnant controls (Treatment D). Ultrasound-guided transvaginal oocyte aspiration was performed 12 h following the last FSH or saline injection. Following follicle aspiration, oocytes were matured for 24 h and then entered a standard bovine IVF procedure. Experiment 2 was conducted to determine the repeatability of this procedure on first trimester cows. Cows in Exp. 2 were selected (after a 20-d recovery period) from each of the three pregnant treatment groups in Exp. 1 and each given 40 mg of FSH before a second oocyte aspiration procedure. The number of follicles aspirated per cow in treatment groups receiving the high FSH dose treatment (40 mg of FSH total dose) was not different (Treatment A, Treatment D, and cows in Exp. 2).(ABSTRACT TRUNCATED AT 250 WORDS)
Meintjes
M
M
Department of Physiology, Pharmacology, and Toxicology, School of Veterinary Medicine, Louisiana State University Agricultural Center, Baton Rouge 70803, USA.
Bellow
M S
MS
Broussard
J R
JR
Paul
J B
JB
Godke
R A
RA
D000818:Animals; D002417:Cattle / Q000502:physiology*; D002469:Cell Separation / Q000379:methods; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D005640:Follicle Stimulating Hormone / Q000494:pharmacology*; D018587:Oocyte Donation; D009865:Oocytes / Q000166:cytology* / Q000502:physiology; D006080:Ovarian Follicle / Q000166:cytology / Q000187:drug effects; D010053:Ovary / Q000000981:diagnostic imaging; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology*; D011897:Random Allocation; D013396:Suction / Q000009:adverse effects / Q000379:methods / Q000662:veterinary; D014463:Ultrasonography
D005640:Follicle Stimulating Hormone